Aqsens Health’s new insider in Boston – Uzma Riyaz joins the team as a Project Coordinator
Aqsens Health is pleased to welcome Uzma Ryiaz to the team. Uzma joins Aqsens Health as a Project Coordinator, initially supporting our research collaboration with Harvard Medical School in Boston, and later expanding to other projects in the area.
Executing an impactful urinary tract cancers strategy – when opportunity grabs you by the hand
In this blog post Aqsens Health’s CEO and Co-founder Timo Teimonen recounts Aqsens’ urinary tract cancer strategy journey and discusses the importance of international collaboration and multidisciplinary approaches in advancing cancer research.
Strengthening Aqsens Health’s board with diagnostics market expertise
We're pleased to welcome Paul Eros to our Board of Directors and announce Pekka Hänninen as our new Chairman. We're deeply grateful to Aaron Michelin for his contributions and look forward to continued collaboration.
What are Phages? – A look into their history and applications
Vilhelmiina Juusti Appointed as a COO of Aqsens Health Oy Ltd.
Aqsens Health Oy Ltd., a leading provider of biosensor based analysis, is pleased to announce the appointment of Vilhelmiina Juusti as its new Chief Operating Officer (COO).
Mr. Paul Eros brings over 25 years of executive experience in diagnostics to Aqsens Health as a Senior Business Advisor
Mr. Paul Eros has a proven track record of excellence in the in-vitro diagnostics field with expertise from executive management to global marketing, sales and product management. Now he is joining Aqsens Health’s team as a Senior Business Advisor, bringing with him a wealth of experience in commercialization, productization and in market entry strategies.
Could biosensors enable better prediction for organ transplantation rejection – a research project with the Department of Medicine, Harvard Medical School Lung Transplantation team
Aqsens Health had a chance to interview Dr. Mohd Moin Khan and Dr. Mudassir Meraj Banday, research fellows at Harvard University, about their research, this collaboration, and how we could use biosensors in the future to help predict the likelihood of rejection in organ transplants. Below are their answers to our questions.
Daily Decisions, Lasting Effects: Impacting Your Cancer Risk – World Cancer Day 2024
Did you know that a third of the most prevalent cancers can be prevented through simple, healthy lifestyle choices? According to the World Health Organization (WHO), embracing specific changes in your daily routine and adopting evidence-based prevention strategies can help steer clear of approximately 30% to 50% of cancer-related deaths.
Kicking-off saliva based Parkinson’s disease detection study using E-TRF and biosensors – Interview with Professor Valtteri Kaasinen from University of Turku
Aqsens Health is excited to take part in a cross-disciplinary Parkinson’s disease study in collaboration with Professor Valtteri Kaasinen from The Department of Clinical Neurosciences at the University of Turku. The aim of the study is to improve Parkinson’s disease’s diagnostic accuracy with Aqsens’ E-TRF and biosensor technology and smell detection dogs. We had the pleasure to interview Professor Kaasinen about Parkinson’s disease (PD), its diagnostics, and how this study could help improve diagnostics in the future.
Aqsens Health’s 2023 wrap-up
It’s time to wrap-up Aqsens Health’s 2023, a year of major scientific steps and large clinical trial kick-offs!
AQ Lab beta testing completed and the platform is ready for commercial deployment
After a year of development and a few months of final beta testing, AQ Lab is ready to be deployed as a research and development platform for E-TRF and biosensor-based projects.
Aqsens Health starting pre-clinical trials for urinary tract cancer detection in China
Aqsens Health and its Chinese partner OG Pharmaceuticals have received funding for a joint prostate and bladder cancer pre-clinical and clinical research project in Jiangsu Province in China.
Professor Tambet Teesalu joins Aqsens Health’s scientific advisors as a Senior Advisor in biosensor technology
Aqsens Health is happy to share that our scientific advisory team will be strengthened with Professor Tambet Teesalu’s phage and biosensor expertise.
“Finns don’t joke with time” – Elizabeth is back and getting settled into her life in Finland
After two years of working together with Aqsens Health through our malaria research project with the Noguchi Memorial Institute for Medical Research in Ghana, Elizabeth Cudjoe returned to Finland to work as a Senior Application Scientist at Aqsens Health.
Paving the way to the world’s largest single market – Interview with Aqsens Health’s Senior Project Manager Zhao Zhao
Zhao took the time to answer a few questions about her role at Aqsens, what she looks forward to when managing impactful projects in China , and what she thinks are the most important success factors when collaborating with Chinese partners.
Aqsens Health, Tyks and Auria Biobank join forces for a research study to detect and classify bladder cancer with phage-biosensors
Aqsens Health, Turku University Hospital (Tyks) and Auria Biobank join forces for a bladder cancer research study. This local research collaboration aims to see whether Aqsens Health’s biosensors can be used in the detection and classification of bladder cancer, focusing especially on non-invasive monitoring of bladder cancer tumor development, relapse, and recurrence.
BIOSALIVA – Aqsens Health and Shanghai Jiao Tong University begin research on early detection of lung cancer and tuberculosis
Aqsens Health and research teams from the Shanghai Jiao Tong University and Shanghai Public Health Clinical Center have received research funding from China’s Ministry of Science and Technology and Business Finland to start a research collaboration focusing on the detection of lung cancer and tuberculosis from saliva samples.
Aqsens Health and Tartu University teaming up to research the capabilities of different phages as biosensors in diagnostics
Aqsens Health is pleased to announce its collaboration with Professor Tambet Teesalu's esteemed research group at the Laboratory of Precision and Nanomedicine, University of Tartu in Estonia. Together, they will delve into extensive research to explore the capabilities of different phages as biosensors.
Bladder cancer FAQ – Bladder cancer awareness month 2023
What is bladder cancer and how is it currently diagnosed? How common is it? What are the usual symptoms? Every May the World Bladder Cancer Patient Coalition celebrates bladder cancer awareness month.
How AI is shaping the Medtech industry – Interview with Professor Wei Dongqing from Shanghai Jiao Tong University
We at Aqsens Health had the opportunity to interview Professor Wei Dongqing to discuss how AI is shaping the future of the healthcare industry ahead of Aqsens and Shanghai Jiao Tong University's upcoming research collaboration.